S1PR3 and post-traumatic stress disorder: Interestingly, Corbett et al. found that S1PR3 mRNA correlates negatively with the severity of posttraumatic stress disorder (PTSD) symptoms and may provide the groundwork for the development of treatment strategies targeting sphingolipid receptors for stress-related psychiatric disorders, including PTSD, anxiety, and depression [56].